Toralf Reimer - Gynecology

Author Information

Dr. Toralf Reimer is affiliated with the Department of Obstetrics and Gynecology at the University of Rostock, located in Rostock, Germany. He has made significant contributions to the field of Gynecology, particularly focusing on breast cancer research.

Research Contributions

Dr. Reimer has an extensive body of work dedicated to breast cancer research. In 2022 alone, he has contributed to studies on various aspects of breast cancer, including patient-reported outcomes, molecular plasticity, the impact of anthracyclines, intelligent biopsy techniques, and the effects of capecitabine as part of chemotherapy. His research often explores the effectiveness of different treatments and methodologies in improving patient outcomes in early-stage and high-risk breast cancer.

Aliases

Dr. Toralf Reimer is also known by the names T. Reimer and T Reimer in various publications.

Publication and Citation Metrics

Metric	Value
Citation Count	7165
h-index	41
Paper Count	261

Publications:

Abstract GS4-03: Patient-reported outcomes (PROs) for the intergroup sentinel mamma study (INSEMA, GBG75, ABCSG43): Persistent impact of axillary surgery on arm and breast symptoms in early breast cancer

DOI: 10.1158/1538-7445.sabcs21-gs4-03

Year: 2022

Abstract PD2-04: Molecular plasticity of luminal breast cancer and response to CDK 4/6 inhibition - The biomarker program of the PENELOPE-B trial investigating post-neoadjuvant palbociclib

DOI: 10.1158/1538-7445.sabcs21-pd2-04

Year: 2022

Abstract OT1-02-01: Phase III postneoadjuvant study evaluating sacituzumab govitecan (SG), an antibody drug conjugate in primary HER2-negative breast cancer patients with high relapse risk after standard neoadjuvant treatment - SASCIA

DOI: 10.1158/1538-7445.sabcs21-ot1-02-01

Year: 2022

The impact of anthracyclines in intermediate and high-risk HER2-negative early breast cancer-a pooled analysis of the randomised clinical trials PlanB and SUCCESS C.

DOI: 10.1038/s41416-021-01690-6

Year: 2022

Intelligent Vacuum-Assisted Biopsy to Identify Breast Cancer Patients With Pathologic Complete Response (ypT0 and ypN0) After Neoadjuvant Systemic Treatment for Omission of Breast and Axillary Surgery.

DOI: 10.1200/JCO.21.02439

Year: 2022

Effects of capecitabine as part of neo-/adjuvant chemotherapy - A meta-analysis of individual breast cancer patient data from 13 randomised trials including 15,993 patients.

DOI: 10.1016/j.ejca.2022.02.003

Year: 2022

Abstract P5-13-36: Germline BRCA1/2 and other predisposition genes in high-risk early-stage HR+/HER2- breast cancer (BC) patients treated with endocrine therapy (ET) with or without palbociclib: A secondary analysis from the PENELOPE-B study

DOI: 10.1158/1538-7445.sabcs21-p5-13-36

Year: 2022

Abstract PD7-02: Intelligent vacuum-assisted breast biopsy to identify breast cancer patients with pathologic complete response after neoadjuvant systemic treatment for omission of breast and axillary surgery

DOI: 10.1158/1538-7445.sabcs21-pd7-02

Year: 2022

False-negative rate in the extended prospective TATTOO trial evaluating targeted axillary dissection by carbon tattooing in clinically node-positive breast cancer patients receiving neoadjuvant systemic therapy

DOI: 10.1007/s10549-022-06588-2

Year: 2022

De-escalated neoadjuvant pertuzumab plus trastuzumab therapy with or without weekly paclitaxel in HER2-positive, hormone receptor-negative, early breast cancer (WSG-ADAPT-HER2+/HR-): survival outcomes from a multicentre, open-label, randomised, phase 2 trial.

DOI: 10.1016/s1470-2045(22)00159-0

Year: 2022

Who Can Benefit from Ovarian Tissue Freezing?

When to Consult a Gynecologist?

Do I Have to Pay a Co Pay for Emergency Gynecological Services?

How Do Pathologists Diagnose Gynecological Conditions?

How do Hormonal Shifts Affect the Menstrual Cycle?

How Does Radiotherapy Work?

Why Are UTI Test Kits Important in Gynecology?

How Are Twins Diagnosed?

What Types of Products Should Be Fragrance-Free?

4. What Are the Guidelines for Physical Examinations?

Partnered Content Networks

Relevant Topics